To save lives, the FDA must change how it evaluates rare disease treatments
For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients
Source: yahoo.com
Stay updated with breaking news from Mark Dant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients